XML 53 R29.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock Compensation (Tables)
 12 Months Ended
Dec. 31, 2016
Stock Compensation [Line Items]  
Schedule of stock-based compensation costs
Stock-based compensation costs for the years ended December 31, 2016, 2015 and 2014, are as follows:
 
 
Year Ended December 31,
In thousands
 
2016
 
2015
 
2014
Stock-based compensation expensed
 
 
 
 
 
 
General and administrative expenses
 
$
14,359

 
$
27,995

 
$
27,789

Lease operating expenses
 
636

 
2,609

 
2,724

Total stock-based compensation expensed
 
14,995

 
30,604

 
30,513

Stock-based compensation capitalized
 
6,047

 
8,681

 
9,019

Total cost of stock-based compensation arrangements
 
$
21,042

 
$
39,285

 
$
39,532

 
 
 
 
 
 
 
Income tax benefit recognized for stock-based compensation arrangements
 
$
5,698

 
$
11,630

 
$
11,595
Schedule of SARs valuation assumptions
 
 
Year Ended December 31,
 
 
2015
 
2014
Weighted average fair value of SARs granted
 
$
1.77

 
$
3.55

Risk-free interest rate
 
1.29
%
 
1.31
%
Expected life
 
4.0 years

 
3.8 to 4.0 years

Expected volatility
 
39.4
%
 
38.0
%
Dividend yield
 
3.42
%
 
3.10
%
  
Summary of stock option and SARs activity
The following is a summary of our stock option and SAR activity:
 
 
Number
of Awards
 
Weighted
Average
Exercise Price
 
Weighted Average Remaining Contractual Life
(in years)
 
Aggregate Intrinsic Value
(in thousands)
Outstanding at December 31, 2015
 
8,903,514

 
$
13.76

 
 
 
 
Granted
 
—

 
—

 
 
 
 
Exercised
 
—

 
—

 
 
 
 
Forfeited
 
(365,410
)
 
8.21

 
 
 
 
Expired
 
(2,597,360
)
 
14.98

 
 
 
 
Outstanding at December 31, 2016
 
5,940,744

 
13.57

 
3.0
 
$
—

 
 
 
 
 
 
 
 
 
Exercisable at end of period
 
4,198,913

 
$
15.99

 
2.1
 
$
—
Disclosure of intrinsic value of stock options exercised and grant-date fair value of awards vested
The following is a summary of the total intrinsic value of stock options and SARs exercised and grant-date fair value of stock options and SARs vested:
 
 
Year Ended December 31,
In thousands
 
2016
 
2015
 
2014
Intrinsic value of stock options and SARs exercised
 
$
—

 
$
60

 
$
7,985

Grant-date fair value of stock options and SARs vested
 
4,787

 
6,534

 
9,998
Summary of cash received from stock option exercises and tax benefit realized for the exercises of stock options and SARs
The following is a summary of cash received from stock option exercises under share-based payment arrangements and tax benefits realized from the exercises of stock options and SARs:
 
 
Year Ended December 31,
In thousands
 
2016
 
2015
 
2014
Cash received from stock option exercises
 
$
—

 
$
562

 
$
7,022

Tax benefit realized for the exercises of stock options and SARs
 
—

 
—

 
212
Restricted Stock [Member]  
Stock Compensation [Line Items]  
Summary of the total vesting date fair value of non-performance-based restricted stock and performance-based equity awards
The following is a summary of the total vesting date fair value of non-performance-based restricted stock:
 
 
Year Ended December 31,
In thousands
 
2016
 
2015
 
2014
Fair value of restricted stock vested
 
$
6,161

 
$
12,549

 
$
24,780
Summary of non-performance-based restricted stock activity
A summary of the status of our nonvested non-performance-based restricted stock grants issued, and the changes during the year ended December 31, 2016, is presented below:
 
 
Number
of Shares
 
Weighted
Average
Grant-Date
Fair Value
Nonvested at December 31, 2015
 
5,589,687

 
$
9.27

Granted
 
7,569,553

 
3.23

Vested
 
(2,906,465
)
 
10.44

Forfeited
 
(511,990
)
 
7.09

Nonvested at December 31, 2016
 
9,740,785

 
4.34
Performance-based equity awards [Member]  
Stock Compensation [Line Items]  
Summary of the total vesting date fair value of non-performance-based restricted stock and performance-based equity awards
The following is a summary of the total vesting date fair value of performance-based equity awards:
 
 
Year Ended December 31,
In thousands
 
2016
 
2015
 
2014
Vesting date fair value of Performance-Based Operational Awards
 
$
—

 
$
2,861

 
$
—

Vesting date fair value of Performance-Based TSR Awards
 
81

 
300

 
—
Schedule of nonvested performance-based Units Activity
A summary of the status of the nonvested performance-based equity awards (presented at the target level) during the year ended December 31, 2016, is as follows:
 
 
Performance-Based
Operational Awards
 
Performance-Based
TSR Awards
 
 
Number
of Awards
 
Weighted
Average
Grant-Date Fair Value
 
Number
of Awards
 
Weighted
Average
Grant-Date Fair Value
Nonvested at December 31, 2015
 
559,260

 
$
13.82

 
768,555

 
$
14.75

Granted (1)
 
596,445

 
2.17

 
1,491,112

 
1.78

Vested (2)
 
(139,049
)
 
7.31

 
(145,731
)
 
20.08

Forfeited
 
(52,221
)
 
5.58

 
(97,513
)
 
4.94

Nonvested at December 31, 2016
 
964,435

 
8.00

 
2,016,423

 
5.25


(1)
Amounts granted reflect the number of performance units granted. The actual payout of the shares may be between 0% and 200%, with any amounts earned above the 100% target levels payable in cash, rather than in shares of Denbury stock, in order to conserve available shares under the Plan.
(2)
During 2016, the service period lapsed on these performance unit awards. The lapsed units earned a weighted average of 0% and 25% of target for each vested Operational and TSR performance-based award, respectively, representing 36,434 aggregate shares of common stock issued.
Performance-Based TSR Awards [Member]  
Stock Compensation [Line Items]  
Summary of Performance-Based TSR Awards Valuation Assumptions
The range of assumptions used in the Monte Carlo simulation valuation approach for Performance-Based TSR Awards (presented at the target level) are as follows:
 
 
Year Ended December 31,
 
 
2016
 
2015
 
2014
Weighted average fair value of Performance-Based TSR Awards granted
 
$
1.78

 
$
7.59

 
$
19.81

Risk-free interest rate
 
1.31
%
 
0.96
%
 
0.80
%
Expected life
 
3.0 years

 
3.0 years

 
3.0 years

Expected volatility
 
57.2
%
 
33.6
%
 
39.4
%
Dividend yield
 
—
%
 
3.42
%
 
2.50
%